{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T07:34:00Z","timestamp":1784878440621,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:00:00Z","timestamp":1419379200000},"content-version":"vor","delay-in-days":1606,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1111\/j.1469-0691.2010.03122.x","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T12:22:17Z","timestamp":1266322937000},"page":"1274-1281","source":"Crossref","is-referenced-by-count":48,"title":["A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized subjects with complicated intra-abdominal infections"],"prefix":"10.1016","volume":"16","author":[{"given":"S.","family":"Towfigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Leister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Babinchak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2010.03122.x_bib1","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.clinthera.2008.11.006","article-title":"Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the united states: results from the tigecycline evaluation and surveillance trial (test) 2005 to 2007","volume":"30","author":"Dowzicky","year":"2008","journal-title":"Clin Ther"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1179\/joc.2009.21.1.16","article-title":"Antimicrobial susceptibility among bacterial isolates from icu and non-icu setting and different age groups: results from the tigecycline evaluation and surveillance trial in north america","volume":"21","author":"Low","year":"2009","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.43.4.738","article-title":"In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (gar-936)","volume":"43","author":"Petersen","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1590\/S1413-86702008000500012","article-title":"Rates of antimicrobial resistance in latin america (2004\u20132007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics","volume":"12","author":"Rossi","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijsu.2005.03.011","article-title":"Tigecycline is efficacious in the treatment of complicated intra-abdominal infections","volume":"3","author":"Fomin","year":"2005","journal-title":"Int J Surg"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2334-5-88","article-title":"A multicenter trial of the efficacy and safety of tigecycline versus imipenem\/cilastatin in patients with complicated intra-abdominal infections [study id numbers: 3074a1-301-ww; clinicaltrials.Gov identifier: Nct00081744]","volume":"5","author":"Oliva","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.suc.2008.12.001","article-title":"Intra-abdominal infections","volume":"89","author":"Mazuski","year":"2009","journal-title":"Surg Clin North Am"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib8","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.surg.2009.06.051","article-title":"Mortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infection","volume":"146","author":"Inui","year":"2009","journal-title":"Surgery"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/archsurg.1996.01430180067014","article-title":"Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients","volume":"131","author":"Pacelli","year":"1996","journal-title":"Arch Surg"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s10096-004-1199-0","article-title":"Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery","volume":"23","author":"Krobot","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"suppl 6","key":"10.1111\/j.1469-0691.2010.03122.x_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-0691.2008.02123.x","article-title":"Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections \u2013 are they applicable today?","volume":"14","author":"Cainzos","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1469-0691.2010.03122.x_bib12","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/378702","article-title":"Guidelines for the selection of antiinfective agent for complicated intra-abdominal infections","volume":"37","author":"Solomkin","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"suppl 5","key":"10.1111\/j.1469-0691.2010.03122.x_bib13","doi-asserted-by":"crossref","first-page":"S354","DOI":"10.1086\/431676","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data","volume":"41","author":"Babinchak","year":"2005","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14642300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,26]],"date-time":"2019-05-26T00:18:57Z","timestamp":1558829937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14642300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1198743X14642300"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03122.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}